Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroSafe Group is a private healthcare products company focused on infection prevention, disinfection, wound care, dermatology, personal care, and animal care. The company markets commercial products rather than a traditional drug-development pipeline, with a particular emphasis on Nanocyn disinfectant products manufactured in partnership with Sonoma Pharmaceuticals using Sonoma's Microcyn stabilized hypochlorous acid technology. MicroSafe Group appears to operate internationally from Dubai and promotes its products across the U.S., Europe, Australia, and other markets. Its business is centered on commercialization and distribution of non-toxic antimicrobial and wound-care products for hospitals, healthcare providers, government facilities, and related end markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microsafe Care Group.